Adherence
Patient preferences for GLP-1 receptor agonist outcomes vary substantially by demographic factors (age, sex, BMI), with younger individuals and women expressing significantly higher concern regarding cosmetic side effects like alopecia and severe gastrointestinal outcomes compared to older men.
If you are considering GLP-1 medication, your personal tolerance for side effects matters more than the average patient's experience. Younger women, in particular, may find hair loss or GI issues more distressing than older men. Discuss these specific fears with your doctor before starting, as they significantly impact whether you will stick with the treatment long enough to see benefits.
Younger participants tended to be more concerned about outcomes requiring more intensive treatment... as well as outcomes such as alopecia and injection-site reactions. For instance, younger women expressed greater concern about alopecia, whereas men, particularly older men, were comparatively less concerned.
Why this rating
Large multinational sample (n=2112) with robust statistical modeling (Bayesian hierarchical), though it is a preference survey (observational) rather than a clinical trial.
Source
Preferences for benefit and harm outcomes of GLP-1 receptor agonists in adults with overweight or obesity: a multinational best–worst scaling study
Hannah Moll et al. · medRxiv · 2025
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →